d’Hervé, Q.
Girerd, N. http://orcid.org/0000-0002-3278-2057
Bozec, E.
Lamiral, Z.
Panisset, V.
Frimat, L.
Huttin, O.
Girerd, S.
Article History
Received: 18 January 2023
Accepted: 11 April 2023
First Online: 21 April 2023
Declarations
:
: Pr GIRERD received personal fees from Novartis, Pfizer, Astra Zeneca, Boehringer, Vifor, Bayer and Lilly. All other authors declared no competing interest.